Neuralink's Milestone: First Human Implantation in the PRIME Study
Neuralink has achieved a remarkable milestone with the first human implantation of their brain-computer interface (BCI) technology. This eve...
-
Neuralink has achieved a remarkable milestone with the first human implantation of their brain-computer interface (BCI) technology. This eve... -
In a significant stride towards combating urinary tract infections (UTIs) in women, the U.S. Food and Drug Administration (FDA) has approved...
-
The FDA approved two groundbreaking cell-based gene therapies, Casgevy and Lyfgenia, for treating sickle cell disease (SCD) in patients ag...